GlassScriptPhysician profile
Ritu P Patel
NPI 1730421751
$1,600.63
in general payments reported to CMS, 2019-2025
16 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $94.01 · 2021: $319 · 2022: $138 · 2023: $229 · 2024: $329 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $349.69 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $213.79 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $169.70 | 2024 | Krystexxa |
| Lilly USA, LLC | $143.04 | 2020-2023 | Mounjaro, Jardiance |
| Vifor Pharma, INC. | $134.25 | 2019-2022 | |
| Medtronic, INC. | $121.59 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.42 | 2023 | Lifevest |
| Intuitive Surgical, INC. | $76.93 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $66.34 | 2020-2024 | Jynarque |
| Pulmonx Corporation | $62.73 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Horizon Therapeutics Plc | $45.82 | 2019-2021 | |
| Dexcom, INC. | $45.36 | 2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $25.53 | 2019 | |
| Abbott Laboratories | $19.18 | 2021 | |
| Akebia Therapeutics INC | $16.56 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritu Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.